Digital ad spending in the US healthcare and pharmaceutical industry will grow by 14.2% to reach $9.53 billion in 2020. Growth is being fueled by ads related to COVID-19, including public service announcements, medical supplies and telemedicine.
But this roadblock isn’t holding back the medical device ecosystem from making progress: The Medical Device Innovation Consortium (MDIC) created a working group in November 2020 to bring key stakeholders together with the goal, championed by the Food and Drug Administration (FDA), to improve the process for development and assessment of novel 5G-enabled medical devices and wearables.
“The elements that constitute the experience funnel tend to live in different divisions and silos, and there is no one charged with orchestrating it,” said Todd Unger, chief experience officer at the American Medical Association. “Today’s digital environment demands an operating leader who understands the new paradigm and can lead that orchestration—and has the authority to do it.”